Abstract Introduction The Covid-19 pandemic affects maternal health both directly and
indirectly, and direct and indirect effects are intertwined. To provide a comprehensive …

Objective To examine the relationship between SARS-CoV-2 infection during pregnancy
and the risk for preeclampsia. Data Sources MEDLINE, Embase, POPLINE, CINAHL …

Population-level data on COVID-19 vaccine uptake in pregnancy and SARS-CoV-2 infection
outcomes are lacking. We describe COVID-19 vaccine uptake and SARS-CoV-2 infection in …

Background Infants younger than 6 months of age are at high risk for complications of
coronavirus disease 2019 (Covid-19) and are not eligible for vaccination. Transplacental …

To evaluate the effectiveness of the BNT162b2 messenger RNA vaccine in pregnant
women, we conducted an observational cohort study of pregnant women aged 16 years or …

Importance Pregnant women are at increased risk of morbidity and mortality from COVID-19
but have been excluded from the phase 3 COVID-19 vaccine trials. Data on vaccine safety …

Background Pregnant and lactating women were excluded from initial coronavirus disease
2019 vaccine trials; thus, data to guide vaccine decision making are lacking. Objective This …

With the development of multiple effective vaccines, reducing the global morbidity and
mortality of COVID-19 will depend on the distribution and acceptance of COVID-19 …

Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against
COVID-19–Associated Hospitalization in Infants Aged 6 Months — 17 States, July …

In a retrospective cohort of> 40,000 pregnant women, COVID-19 vaccination during
pregnancy was not associated with preterm birth or small-for-gestational-age at birth overall …